Skip to content

Savara SVRA Interest Expense

Interest Expense at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$6.88M-5.8%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$5.44M+15.4%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$582K-9.5%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$3.77M+31.3%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
-$840K+18.3%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$3.46M+529%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+134%
Enterprise value$1.19B+127%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's interest expense?
Savara (SVRA) reported interest expense of $1.06M in Q1 2026.
How has Savara's interest expense changed year-over-year?
Savara's interest expense decreased by 29.4% year-over-year, from $1.5M to $1.06M.
What is the long-term trend for Savara's interest expense?
Over 3 years (2021 to 2025), Savara's interest expense has grown at a 22.2% compound annual growth rate (CAGR), from -$2.28M to $4.16M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.